Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosis
Summary: Background: Although diabetes and poor glycaemic control significantly increase the risk of tuberculosis and adversely affect tuberculosis treatment outcomes, the global burden of diabetes in the context of tuberculosis remains unknown. We did a systematic review and meta-analysis to estim...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-04-01
|
Series: | The Lancet Global Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214109X1830487X |
id |
doaj-7bba158a857f4ae0bf0a5a7172dd0efe |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jean Jacques Noubiap, MD Jobert Richie Nansseu, MD Ulrich Flore Nyaga, MD Jan René Nkeck, MD Francky Teddy Endomba, MD Arnaud D Kaze, MD Valirie N Agbor, MD Jean Joel Bigna, MD |
spellingShingle |
Jean Jacques Noubiap, MD Jobert Richie Nansseu, MD Ulrich Flore Nyaga, MD Jan René Nkeck, MD Francky Teddy Endomba, MD Arnaud D Kaze, MD Valirie N Agbor, MD Jean Joel Bigna, MD Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosis The Lancet Global Health |
author_facet |
Jean Jacques Noubiap, MD Jobert Richie Nansseu, MD Ulrich Flore Nyaga, MD Jan René Nkeck, MD Francky Teddy Endomba, MD Arnaud D Kaze, MD Valirie N Agbor, MD Jean Joel Bigna, MD |
author_sort |
Jean Jacques Noubiap, MD |
title |
Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosis |
title_short |
Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosis |
title_full |
Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosis |
title_fullStr |
Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosis |
title_full_unstemmed |
Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosis |
title_sort |
global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosis |
publisher |
Elsevier |
series |
The Lancet Global Health |
issn |
2214-109X |
publishDate |
2019-04-01 |
description |
Summary: Background: Although diabetes and poor glycaemic control significantly increase the risk of tuberculosis and adversely affect tuberculosis treatment outcomes, the global burden of diabetes in the context of tuberculosis remains unknown. We did a systematic review and meta-analysis to estimate the prevalence of diabetes among patients with tuberculosis at global, regional, and country levels. Methods: We searched PubMed, Excerpta Medica Database, Web of Science, and Global Index Medicus to identify studies published between Jan 1, 1986, and June 15, 2017, on the prevalence of diabetes in patients with active tuberculosis, with no language restrictions. Criteria to diagnose tuberculosis and diabetes concurred with WHO guidelines. Methodological quality of eligible studies was assessed, and random-effect models meta-analysis served to obtain the pooled prevalence estimate of diabetes among patients with active tuberculosis, globally. Heterogeneity (I2) was assessed via the χ2 test on Cochran's Q statistic. This study is registered with PROSPERO, number CRD42016049901. Findings: We screened 7565 records of which 200 studies (2 291 571 people with active tuberculosis) were included in meta-analyses. The pooled prevalence of diabetes was 15·3% (95% prediction interval 2·5–36·1; I2 99·8%), varying from 0·1% in Latvia to 45·2% in Marshall Islands. Subgroup and metaregression analyses for identifying sources of heterogeneity showed that four International Diabetes Federation (IDF) regions (North America and Caribbean [19·7%], western Pacific [19·4%], southeast Asia [19·0%], Middle East and North Africa [17·5%]) had significantly higher prevalence estimates than the three others (Africa [8·0%], South and Central America [7·7%], and Europe [7·5%]; p<0·0001). Additionally, the prevalence increased with age, in men, and in countries with low tuberculosis burden. The prevalence of diabetes was decreased in countries that had low incomes and low Human Development Index scores. The form of tuberculosis infection and presence of HIV seemed not to affect the prevalence of diabetes among patients with active tuberculosis. Interpretation: This study suggests a high burden of diabetes among patients with active tuberculosis, with disparities according to age, sex, regions, level of country income, and development. Cost-effective strategies to curb the burden of diabetes among patients with active tuberculosis are needed. Funding: None. |
url |
http://www.sciencedirect.com/science/article/pii/S2214109X1830487X |
work_keys_str_mv |
AT jeanjacquesnoubiapmd globalprevalenceofdiabetesinactivetuberculosisasystematicreviewandmetaanalysisofdatafrom23millionpatientswithtuberculosis AT jobertrichienansseumd globalprevalenceofdiabetesinactivetuberculosisasystematicreviewandmetaanalysisofdatafrom23millionpatientswithtuberculosis AT ulrichflorenyagamd globalprevalenceofdiabetesinactivetuberculosisasystematicreviewandmetaanalysisofdatafrom23millionpatientswithtuberculosis AT janrenenkeckmd globalprevalenceofdiabetesinactivetuberculosisasystematicreviewandmetaanalysisofdatafrom23millionpatientswithtuberculosis AT franckyteddyendombamd globalprevalenceofdiabetesinactivetuberculosisasystematicreviewandmetaanalysisofdatafrom23millionpatientswithtuberculosis AT arnauddkazemd globalprevalenceofdiabetesinactivetuberculosisasystematicreviewandmetaanalysisofdatafrom23millionpatientswithtuberculosis AT valirienagbormd globalprevalenceofdiabetesinactivetuberculosisasystematicreviewandmetaanalysisofdatafrom23millionpatientswithtuberculosis AT jeanjoelbignamd globalprevalenceofdiabetesinactivetuberculosisasystematicreviewandmetaanalysisofdatafrom23millionpatientswithtuberculosis |
_version_ |
1724878078284398592 |
spelling |
doaj-7bba158a857f4ae0bf0a5a7172dd0efe2020-11-25T02:19:09ZengElsevierThe Lancet Global Health2214-109X2019-04-0174e448e460Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosisJean Jacques Noubiap, MD0Jobert Richie Nansseu, MD1Ulrich Flore Nyaga, MD2Jan René Nkeck, MD3Francky Teddy Endomba, MD4Arnaud D Kaze, MD5Valirie N Agbor, MD6Jean Joel Bigna, MD7Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South AfricaDepartment of Public Health, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, CameroonDepartment of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, CameroonDepartment of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, CameroonDepartment of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, CameroonDepartment of Medicine, University of Maryland Medical Center Midtown Campus, Baltimore, MD, USAIbal Sub-divisional Hospital, Oku, Northwest Region, Cameroon; Department of Clinical Research, Health Education and Research Organization (HERO), CameroonDepartment of Epidemiology and Public Health, Centre Pasteur of Cameroon, Yaoundé, Cameroon; Faculty of Medicine, University of Paris Sud XI, Le Kremlin-Bicêtre, France; Correspondence to Dr Jean Joel Bigna, Department of Epidemiology and Public Health, Centre Pasteur of Cameroon, Yaoundé, CameroonSummary: Background: Although diabetes and poor glycaemic control significantly increase the risk of tuberculosis and adversely affect tuberculosis treatment outcomes, the global burden of diabetes in the context of tuberculosis remains unknown. We did a systematic review and meta-analysis to estimate the prevalence of diabetes among patients with tuberculosis at global, regional, and country levels. Methods: We searched PubMed, Excerpta Medica Database, Web of Science, and Global Index Medicus to identify studies published between Jan 1, 1986, and June 15, 2017, on the prevalence of diabetes in patients with active tuberculosis, with no language restrictions. Criteria to diagnose tuberculosis and diabetes concurred with WHO guidelines. Methodological quality of eligible studies was assessed, and random-effect models meta-analysis served to obtain the pooled prevalence estimate of diabetes among patients with active tuberculosis, globally. Heterogeneity (I2) was assessed via the χ2 test on Cochran's Q statistic. This study is registered with PROSPERO, number CRD42016049901. Findings: We screened 7565 records of which 200 studies (2 291 571 people with active tuberculosis) were included in meta-analyses. The pooled prevalence of diabetes was 15·3% (95% prediction interval 2·5–36·1; I2 99·8%), varying from 0·1% in Latvia to 45·2% in Marshall Islands. Subgroup and metaregression analyses for identifying sources of heterogeneity showed that four International Diabetes Federation (IDF) regions (North America and Caribbean [19·7%], western Pacific [19·4%], southeast Asia [19·0%], Middle East and North Africa [17·5%]) had significantly higher prevalence estimates than the three others (Africa [8·0%], South and Central America [7·7%], and Europe [7·5%]; p<0·0001). Additionally, the prevalence increased with age, in men, and in countries with low tuberculosis burden. The prevalence of diabetes was decreased in countries that had low incomes and low Human Development Index scores. The form of tuberculosis infection and presence of HIV seemed not to affect the prevalence of diabetes among patients with active tuberculosis. Interpretation: This study suggests a high burden of diabetes among patients with active tuberculosis, with disparities according to age, sex, regions, level of country income, and development. Cost-effective strategies to curb the burden of diabetes among patients with active tuberculosis are needed. Funding: None.http://www.sciencedirect.com/science/article/pii/S2214109X1830487X |